naltrexone has been researched along with Froehlich's Syndrome in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, EA; Miller, JL; Perez, FA; Roth, CL | 1 |
| Böttcher, B; Dörr, HG; Wildt, L | 1 |
| Leyendecker, G; Waibel-Treber, S; Wildt, L | 1 |
| Leyendecker, G; Sir-Petermann, T; Waibel-Treber, S; Wildt, L | 1 |
| Alba, F; Devoto, L; Kohen, P; Rivera, J; Sir, T | 1 |
| Armeanu, MC; Berkhout, GM; Lambalk, CB; Schoemaker, J | 1 |
| Anserini, P; De Cecco, L; Remorgida, V; Salerno, E; Venturini, PL | 1 |
| Beaufrere, B; Chatelain, P; de Parscau, L; François, R; Loeuille, GA; Ythier, H | 1 |
| Leyendecker, G; Wildt, L | 1 |
1 review(s) available for naltrexone and Froehlich's Syndrome
| Article | Year |
|---|---|
[Hypothalamic dysfunction. 2 cases: the contribution of nuclear magnetic resonance, therapeutic trial of naltrexone].
Topics: Body Height; Body Weight; Child, Preschool; Feeding Behavior; Female; Fever; Humans; Hypernatremia; Hypothalamic Diseases; Hypothermia; Magnetic Resonance Imaging; Male; Naltrexone; Obesity; Pituitary Function Tests | 1989 |
1 trial(s) available for naltrexone and Froehlich's Syndrome
| Article | Year |
|---|---|
Naltrexone in functional hypothalamic amenorrhea and in the normal luteal phase.
Topics: Adult; Amenorrhea; Double-Blind Method; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Hypothalamic Diseases; Luteal Phase; Luteinizing Hormone; Menstrual Cycle; Naltrexone; Reference Values | 1990 |
7 other study(ies) available for naltrexone and Froehlich's Syndrome
| Article | Year |
|---|---|
Oxytocin and Naltrexone Successfully Treat Hypothalamic Obesity in a Boy Post-Craniopharyngioma Resection.
Topics: Administration, Intranasal; Administration, Oral; Child; Craniopharyngioma; Humans; Hypothalamic Diseases; Male; Naltrexone; Neurosurgical Procedures; Obesity; Oxytocin; Pituitary Neoplasms; Treatment Outcome | 2018 |
Naltrexone as a diagnostic tool to distinguish between hyperandrogenemic and hypothalamic ovarian failure in females with congenital adrenal hyperplasia due to 21-hydroxylase-deficiency (CAH).
Topics: Adolescent; Adrenal Hyperplasia, Congenital; Adult; Amenorrhea; Female; Humans; Hyperandrogenism; Hypothalamic Diseases; Naltrexone; Narcotic Antagonists; Oligomenorrhea; Primary Ovarian Insufficiency; Young Adult | 2014 |
Pulsatile administration of gonadotrophin releasing hormone and oral administration of naltrexone in hypothalamic amenorrhoea.
Topics: Amenorrhea; Female; Gonadotropin-Releasing Hormone; Humans; Hypothalamic Diseases; Infertility, Female; Naltrexone; Ovulation; Periodicity; Pregnancy | 1993 |
Treatment with naltrexone in hypothalamic ovarian failure: induction of ovulation and pregnancy.
Topics: Adolescent; Adult; Amenorrhea; Female; Humans; Hypothalamic Diseases; Luteinizing Hormone; Naltrexone; Ovarian Diseases; Ovulation Induction; Pregnancy | 1993 |
[Ovulation induction by the chronic administration of naltrexone in a patient with secondary hypothalamic amenorrhea].
Topics: Adolescent; Amenorrhea; Female; Humans; Hypothalamic Diseases; Menstrual Cycle; Naltrexone; Ovulation Induction; Time Factors | 1992 |
Effects of opioid antagonism with naltrexone on pulsatile luteinizing hormone secretion in women with hypothalamic amenorrhea in basal conditions and after discontinuation of treatment with pulsatile LHRH.
Topics: Adolescent; Adult; Amenorrhea; Endorphins; Female; Gonadotropin-Releasing Hormone; Humans; Hypothalamic Diseases; Luteinizing Hormone; Naltrexone; Pulsatile Flow | 1992 |
Induction of ovulation by the chronic administration of naltrexone in hypothalamic amenorrhea.
Topics: Adult; Amenorrhea; Female; Humans; Hypothalamic Diseases; Luteal Phase; Luteinizing Hormone; Naltrexone; Ovulation Induction; Time Factors | 1987 |